Target intelligence / Profile preview

Non-SSH2 messenger RNAs (Non-SSH2 mRNAs)

Target
Non-SSH2 mRNAs
Molecular classification
Other
01

Overview

Non-SSH2 mRNAs is a collective term referring to the entire population of messenger RNA transcripts in a cell that do not encode the Slingshot Homolog 2 (SSH2) protein. This is not a recognized therapeutic target or a single biological entity; rather, it is a classification used in the development of gene-silencing therapeutics, such as siRNAs or antisense oligonucleotides, to define the off-target transcriptome. SSH2 is a protein phosphatase that plays a critical role in actin cytoskeleton dynamics by dephosphorylating and activating cofilin (UniProt Q76I76, PubMed 12134158). In pharmacological research, ensuring that a drug does not interact with non-SSH2 mRNAs is essential for maintaining high specificity and avoiding unintended gene suppression, which could lead to cellular toxicity or adverse systemic effects (PubMed 15561762). Because this category encompasses thousands of diverse transcripts, it does not have a specific biological function or disease role. The term is primarily used to denote the absence of unintended interactions during the validation of gene-specific knockdown or modulation strategies.

Other names
Non-Slingshot-2 mRNAsOff-target transcriptsBackground transcriptome
02

Mechanism of action

None

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Off-target effectsUnintended gene silencingNon-specific toxicity

Beyond the preview

Go deeper on Non-SSH2 messenger RNAs (Non-SSH2 mRNAs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-SSH2 messenger RNAs (Non-SSH2 mRNAs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call